{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:16:22Z","timestamp":1789578982148,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"7","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771089"],"award-info":[{"award-number":["81771089"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004921","name":"Biological sample bank project of Ninth People\u2019s Hospital Affiliated with Shanghai Jiao Tong University School of Medicine","doi-asserted-by":"publisher","award":["YBKB201907"],"award-info":[{"award-number":["YBKB201907"]}],"id":[{"id":"10.13039\/501100004921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMP"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n<jats:title>Backgound:<\/jats:title>\n<jats:p>Fangchinoline is a bisbenzylisoquinoline alkaloid extracted from Stephania tetrandra S. Moore that is conventionally used as an analgesic, antirheumatic, and antihypertensive drug in China. However, the application of Fanchinoline in Sj\u00f6gren syndrome (SS) remains unreported.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>This study aimed to identify the potential role of Fangchinoline in the treatment of SS via altering Akt\/mTOR signaling.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>First, we examined levels of p-Akt and p-mTOR in infiltrating lymphocytes of labial glands from SS patients by immunohistochemistry. Then, the effects of Fangchinoline on Raji cells and Daudi cells were investigated using the CCK-8 assay, propidium iodide (PI)\/RNase, and Annexin V\/PI staining. Western blotting was used to identify the levels of Akt, p-Akt(ser473), mTOR, and p-mTOR. For in vivo analyses, NOD\/Ltj and wild-type ICR mice were treated with a Fangchinoline solution, an LY294002 solution (an inhibitor of the PI3K\/Akt\/mTOR pathway), or their solvent for 28 days. Then, salivary flow assays and hematoxylin and eosin staining of submandibular glands were performed to determine the severity of SS-like responses in the mice.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Immunohistochemical staining of labial glands from SS patients showed that activation of p-Akt and p-mTOR in infiltrating lymphocytes might be correlated with SS development. In vitro, Fangchino-line and LY294002 inhibited proliferation, induced cell cycle arrest, and promoted apoptosis in Raji and Daudi cells by altering Akt\/mTOR signaling. In vivo, Fangchinoline and LY294002 significantly im-proved the salivary secretion by NOD\/Ltj mice and reduced the number of lymphocytic foci in the sub-mandibular glands.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>These results indicated that Fangchinoline could effectively inhibit the proliferation of neo-plastic B-lymphoid cells and reduce SS-like responses in NOD\/Ltj mice. Our study highlights the poten-tial value of the clinical application of Fangchinoline for SS treatment.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1874467215666220217103233","type":"journal-article","created":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T05:47:22Z","timestamp":1645163242000},"page":"969-979","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Fangchinoline Inhibited Proliferation of Neoplastic B-lymphoid Cells and\nAlleviated Sj\u00f6gren\u2019s Syndrome-like Responses in NOD\/Ltj Mice via the\nAkt\/mTOR Pathway"],"prefix":"10.1016","volume":"15","author":[{"given":"Yanxiong","family":"Shao","sequence":"first","affiliation":[{"name":"Department of Oral Surgery, Shanghai Ninth People\u2019s Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"National Clinical Research Center of Oral Disease, Shanghai, China"},{"name":"Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuangqi","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Oral Surgery, Shanghai Ninth People\u2019s Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"National Clinical Research Center of Oral Disease, Shanghai, China"},{"name":"Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayao","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Oral Surgery, Shanghai Ninth People\u2019s Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"National Clinical Research Center of Oral Disease, Shanghai, China"},{"name":"Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianle","family":"Zhan","sequence":"additional","affiliation":[{"name":"Department of Oral Surgery, Shanghai Ninth People\u2019s Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"National Clinical Research Center of Oral Disease, Shanghai, China"},{"name":"Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Oral Surgery, Shanghai Ninth People\u2019s Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"National Clinical Research Center of Oral Disease, Shanghai, China"},{"name":"Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"ref=1","first-page":"139","volume":"25","author":"Tucci M.","year":"2005","unstructured":"Tucci M.; Quatraro C.; Silvestris F.; Sj\u00f6gren\u2019s syndrome: An autoimmune disorder with otolaryngological involvement. Acta Otorhinolaryngol Ital 2005,25(3),139-144","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/acr.21591","volume":"64","author":"Shiboski S.C.","year":"2012","unstructured":"Shiboski S.C.; Shiboski C.H.; Criswell L.; Baer A.; Challacombe S.; Lanfranchi H.; Schi\u00f8dt M.; Umehara H.; Vivino F.; Zhao Y.; Dong Y.; Greenspan D.; Heidenreich A.M.; Helin P.; Kirkham B.; Kitagawa K.; Larkin G.; Li M.; Lietman T.; Lindegaard J.; McNamara N.; Sack K.; Shirlaw P.; Sugai S.; Vollenweider C.; Whitcher J.; Wu A.; Zhang S.; Zhang W.; Greenspan J.; Daniels T.; Sj\u00f6gren\u2019s International Collaborative Clinical Alliance (SICCA) Research Groups. American College of Rheumatology classification criteria for Sj\u00f6gren\u2019s syndrome: a data-driven, expert consensus approach in the Sj\u00f6gren\u2019s International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 2012,64(4),475-487","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s12016-018-8709-9","volume":"56","author":"Anaya J.M.","year":"2019","unstructured":"Anaya J.M.; Restrepo-Jim\u00e9nez P.; Rodr\u00edguez Y.; Rodr\u00edguez-Jim\u00e9nez M.; Acosta-Ampudia Y.; Monsalve D.M.; Pacheco Y.; Ram\u00edrez-Santana C.; Molano-Gonz\u00e1lez N.; Mantilla R.D.; Sj\u00f6gren\u2019s syndrome and autoimmune thyroid disease: Two sides of the same coin. Clin Rev Allergy Immunol 2019,56(3),362-374","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.rdc.2020.05.004","volume":"46","author":"Igoe A.","year":"2020","unstructured":"Igoe A.; Merjanah S.; Scofield R.H.; Sj\u00f6gren syndrome and cancer. Rheum Dis Clin North Am 2020,46(3),513-532","journal-title":"Rheum Dis Clin North Am"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859","volume":"69","author":"Shiboski C.H.","year":"2017","unstructured":"Shiboski C.H.; Shiboski S.C.; Seror R.; Criswell L.A.; Labetoulle M.; Lietman T.M.; Rasmussen A.; Scofield H.; Vitali C.; Bowman S.J.; Mariette X.; International Sj\u00f6gren\u2019s Syndrome Criteria Working Group 2016 american college of rheumatology\/European league against rheumatism classification criteria for primary Sj\u00f6gren\u2019s Syndrome: A consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol 2017,69(1),35-45","journal-title":"Arthritis Rheumatol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"102301","DOI":"10.1016\/j.jaut.2019.06.012","volume":"103","author":"Pacheco Y.","year":"2019","unstructured":"Pacheco Y.; Acosta-Ampudia Y.; Monsalve D.M.; Chang C.; Gershwin M.E.; Anaya J.M.; Bystander activation and autoimmunity. J Autoimmun 2019,103,102301","journal-title":"J Autoimmun"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2019.01.013","volume":"99","author":"Long D.","year":"2019","unstructured":"Long D.; Chen Y.; Wu H.; Zhao M.; Lu Q.; Clinical significance and immunobiology of IL-21 in autoimmunity. J Autoimmun 2019,99,1-14","journal-title":"J Autoimmun"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jdsr.2019.09.006","volume":"55","author":"Ibrahem H.M.","year":"2019","unstructured":"Ibrahem H.M.; B cell dysregulation in primary Sj\u00f6gren\u2019s syndrome: A review. Jpn Dent Sci Rev 2019,55(1),139-144","journal-title":"Jpn Dent Sci Rev"},{"key":"ref=9","unstructured":"Gandolfo, S.; De, Vita.S. Double anti-B cell and anti-BAFF targeting\nfor the treatment of primary Sj\u00f6gren's syndrome. Clin Exp\nRheumatol, 2019, 37 Suppl 118(3), 199-208."},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0378-8741(97)00092-5","volume":"58","author":"Kim H.S.","year":"1997","unstructured":"Kim H.S.; Zhang Y.H.; Oh K.W.; Ahn H.Y.; Vasodilating and hypotensive effects of fangchinoline and tetrandrine on the rat aorta and the stroke-prone spontaneously hypertensive rat. J Ethnopharmacol 1997,58(2),117-123","journal-title":"J Ethnopharmacol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"103431","DOI":"10.1016\/j.bioorg.2019.103431","volume":"94","author":"Zhang Y.C.","year":"2020","unstructured":"Zhang Y.C.; Gao X.Z.; Liu C.; Wang M.X.; Zhang R.R.; Sun J.Y.; Liu Y.F.; \nDesign, synthesis and \nin vitro\nevaluation of fangchinoline derivatives as potential anticancer agents.\n Bioorg Chem 2020,94,103431","journal-title":"Bioorg Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3390\/biom9110696","volume":"9","author":"Kim D.E.","year":"2019","unstructured":"Kim D.E.; Min J.S.; Jang M.S.; Lee J.Y.; Shin Y.S.; Song J.H.; Kim H.R.; Kim S.; Jin Y.H.; Kwon S.; Natural bis-benzylisoquinoline alkaloids-tetrandrine, fangchinoline, and cepharanthine, inhibit human coronavirus OC43 infection of MRC-5 human lung cells. Biomolecules 2019,9(11),696","journal-title":"Biomolecules"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.3390\/molecules24061154","volume":"24","author":"Liu T.","year":"2019","unstructured":"Liu T.; Zeng Q.; Zhao X.; Wei W.; Li Y.; Deng H.; Song D.; Synthesis and biological evaluation of fangchinoline derivatives as anti-inflammatory agents through inactivation of inflammasome. Molecules 2019,24(6),1154","journal-title":"Molecules"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1124\/mol.60.5.1083","volume":"60","author":"Shen Y.C.","year":"2001","unstructured":"Shen Y.C.; Chou C.J.; Chiou W.F.; Chen C.F.; Anti-inflammatory effects of the partially purified extract of radix Stephaniae tetrandrae: Comparative studies of its active principles tetrandrine and fangchinoline on human polymorphonuclear leukocyte functions. Mol Pharmacol 2001,60(5),1083-1090","journal-title":"Mol Pharmacol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/jop.12765","volume":"47","author":"Wei L.","year":"2018","unstructured":"Wei L.; Xiong H.; Li W.; Li B.; Cheng Y.; \nUpregulation of IL-6 expression in human salivary gland cell line by IL-17 \nvia\nactivation of p38 MAPK, ERK, PI3K\/Akt, and NF-&#x3BA;B pathways.\n J Oral Pathol Med 2018,47(9),847-855","journal-title":"J Oral Pathol Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.3389\/fimmu.2019.02229","volume":"10","author":"Tu Y.","year":"2019","unstructured":"Tu Y.; Guo R.; Li J.; Wang S.; Leng L.; Deng J.; Bucala R.; Lu L.; MiRNA regulation of MIF in SLE and attenuation of murine lupus nephritis with miR-654. Front Immunol 2019,10,2229","journal-title":"Front Immunol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jneuroim.2018.08.012","volume":"324","author":"Hou H.","year":"2018","unstructured":"Hou H.; Cao R.; Quan M.; Sun Y.; Sun H.; Zhang J.; Li B.; Guo L.; Song X.; Rapamycin and fingolimod modulate Treg\/Th17 cells in experimental autoimmune encephalomyelitis by regulating the Akt-mTOR and MAPK\/ERK pathways. J Neuroimmunol 2018,324,26-34","journal-title":"J Neuroimmunol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.3892\/ijo.2015.2959","volume":"46","author":"Tian F.","year":"2015","unstructured":"Tian F.; Ding D.; Li D.; Fangchinoline targets PI3K and suppresses PI3K\/AKT signaling pathway in SGC7901 cells. Int J Oncol 2015,46(6),2355-2363","journal-title":"Int J Oncol"},{"key":"ref=19","unstructured":"Care, N.; Animals, N. Guide For the Care And Use Of Laboratory\nAnimals; National Academies Press (US): Washington (DC), 2011."},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jaut.2009.10.004","volume":"34","author":"Christodoulou M.I.","year":"2010","unstructured":"Christodoulou M.I.; Kapsogeorgou E.K.; Moutsopoulos H.M.; Characteristics of the minor salivary gland infiltrates in Sj\u00f6gren\u2019s syndrome. J Autoimmun 2010,34(4),400-407","journal-title":"J Autoimmun"},{"key":"ref=21","author":"Chen C.","year":"2018","unstructured":"Chen C.; Zheng L.Y.;  The expression of bone marrow stromal antigen-2 in primary Sjogren\u2019s syndrome 2018","journal-title":"The expression of bone marrow stromal antigen-2 in primary Sjogren\u2019s syndrome"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1242\/dev.137075","volume":"143","author":"Yu J.S.","year":"2016","unstructured":"Yu J.S.; Cui W.; Proliferation, survival and metabolism: the role of PI3K\/AKT\/mTOR signalling in pluripotency and cell fate determination. Development 2016,143(17),3050-3060","journal-title":"Development"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"102364","DOI":"10.1016\/j.jaut.2019.102364","volume":"110","author":"Mavragani C.P.","year":"2020","unstructured":"Mavragani C.P.; Moutsopoulos H.M.; Sj\u00f6gren\u2019s syndrome: Old and new therapeutic targets. J Autoimmun 2020,110,102364","journal-title":"J Autoimmun"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/mc.23131","volume":"59","author":"Ma G.","year":"2020","unstructured":"Ma G.; Gezer D.; Herrmann O.; Feldberg K.; Schemionek M.; Jawhar M.; Reiter A.; Br\u00fcmmendorf T.H.; Koschmieder S.; Chatain N.; LCP1 triggers mTORC2\/AKT activity and is pharmacologically targeted by enzastaurin in hypereosinophilia. Mol Carcinog 2020,59(1),87-103","journal-title":"Mol Carcinog"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13075-018-1618-8","volume":"20","author":"Wang X.","year":"2018","unstructured":"Wang X.; Zhang C.; Wu Z.; Chen Y.; Shi W.; \nCircIBTK inhibits DNA demethylation and activation of AKT signaling pathway \nvia\nmiR-29b in peripheral blood mononuclear cells in systemic lupus erythematosus.\n Arthritis Res Ther 2018,20(1),118","journal-title":"Arthritis Res Ther"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1530\/EC-20-0045","volume":"9","author":"Jiang X.","year":"2020","unstructured":"Jiang X.; Wang Y.; Li X.; He L.; Yang Q.; Wang W.; Liu J.; Zha B.; Microarray profile of B cells from Graves\u2019 disease patients reveals biomarkers of proliferation. Endocr Connect 2020,9(5),405-417","journal-title":"Endocr Connect"},{"key":"ref=27","first-page":"813","volume":"19","author":"Ren F.","year":"2020","unstructured":"Ren F.; Zhang W.; Lu S.; Ren H.; Guo Y.; NRSN2 promotes breast cancer metastasis by activating PI3K\/AKT\/mTOR and NF-&#x3BA;B signaling pathways. Oncol Lett 2020,19(1),813-823","journal-title":"Oncol Lett"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"109717","DOI":"10.1016\/j.biopha.2019.109717","volume":"123","author":"Si X.","year":"2020","unstructured":"Si X.; Xu F.; Xu F.; Wei M.; Ge Y.; Chenge S.; CADM1 inhibits ovarian cancer cell proliferation and migration by potentially regulating the PI3K\/Akt\/mTOR pathway. Biomed Pharmacother 2020,123,109717","journal-title":"Biomed Pharmacother"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.semcancer.2017.04.015","volume":"48","author":"O\u2019Donnell J.S.","year":"2018","unstructured":"O\u2019Donnell J.S.; Massi D.; Teng M.W.L.; Mandala M.; PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux. Semin Cancer Biol 2018,48,91-103","journal-title":"Semin Cancer Biol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1600-065X.2010.00934.x","volume":"237","author":"Werner M.","year":"2010","unstructured":"Werner M.; Hobeika E.; Jumaa H.; Role of PI3K in the generation and survival of B cells. Immunol Rev 2010,237(1),55-71","journal-title":"Immunol Rev"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jaut.2012.05.014","volume":"39","author":"Cornec D.","year":"2012","unstructured":"Cornec D.; Devauchelle-Pensec V.; Tob\u00f3n G.J.; Pers J.O.; Jousse-Joulin S.; Saraux A.; B cells in Sj\u00f6gren\u2019s syndrome: from pathophysiology to diagnosis and treatment. J Autoimmun 2012,39(3),161-167","journal-title":"J Autoimmun"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"112995","DOI":"10.1016\/j.jep.2020.112995","volume":"260","author":"Zhang Y.","year":"2020","unstructured":"Zhang Y.; Qi D.; Gao Y.; Liang C.; Zhang Y.; Ma Z.; Liu Y.; Peng H.; Zhang Y.; Qin H.; Song X.; Sun X.; Li Y.; Liu Z.; \nHistory of uses, phytochemistry, pharmacological activities, quality control and toxicity of the root of \nStephania tetrandra\nS. Moore: A review.\n J Ethnopharmacol 2020,260,112995","journal-title":"J Ethnopharmacol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"113921","DOI":"10.1016\/j.bcp.2020.113921","volume":"175","author":"Li T.","year":"2020","unstructured":"Li T.; Xu X.H.; Guo X.; Yuan T.; Tang Z.H.; Jiang X.M.; Xu Y.L.; Zhang L.L.; Chen X.; Zhu H.; Shi J.J.; Lu J.J.; Activation of notch 3\/c-MYC\/CHOP axis regulates apoptosis and promotes sensitivity of lung cancer cells to mTOR inhibitor everolimus. Biochem Pharmacol 2020,175,113921","journal-title":"Biochem Pharmacol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13075-020-02249-1","volume":"22","author":"Yoshimoto K.","year":"2020","unstructured":"Yoshimoto K.; Suzuki K.; Takei E.; Ikeda Y.; Takeuchi T.; Elevated expression of BAFF receptor, BR3, on monocytes correlates with B cell activation and clinical features of patients with primary Sj\u00f6gren\u2019s syndrome. Arthritis Res Ther 2020,22(1),157","journal-title":"Arthritis Res Ther"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10238-020-00637-0","volume":"20","author":"Carrillo-Ballesteros F.J.","year":"2020","unstructured":"Carrillo-Ballesteros F.J.; Palafox-S\u00e1nchez C.A.; Franco-Topete R.A.; Mu\u00f1oz-Valle J.F.; Orozco-Barocio G.; Mart\u00ednez-Bonilla G.E.; G\u00f3mez-L\u00f3pez C.E.; Mar\u00edn-Rosales M.; L\u00f3pez-Villalobos E.F.; Luquin S.; Casta\u00f1eda-Ch\u00e1vez A.; Oregon-Romero E.; Expression of BAFF and BAFF receptors in primary Sj\u00f6gren\u2019s syndrome patients with ectopic germinal center-like structures. Clin Exp Med 2020,20(4),615-626","journal-title":"Clin Exp Med"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"5793","DOI":"10.3892\/mmr.2017.7367","volume":"16","author":"Ge F.","year":"2017","unstructured":"Ge F.; Wang F.; Yan X.; Li Z.; Wang X.; Association of BAFF with PI3K\/Akt\/mTOR signaling in lupus nephritis. Mol Med Rep 2017,16(5),5793-5798","journal-title":"Mol Med Rep"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ejphar.2012.06.026","volume":"690","author":"Liu D.","year":"2012","unstructured":"Liu D.; Li P.; Song S.; Liu Y.; Wang Q.; Chang Y.; Wu Y.; Chen J.; Zhao W.; Zhang L.; Wei W.; Pro-apoptotic effect of epigallo-catechin-3-gallate on B lymphocytes through regulating BAFF\/PI3K\/Akt\/mTOR signaling in rats with collagen-induced arthritis. Eur J Pharmacol 2012,690(1-3),214-225","journal-title":"Eur J Pharmacol"}],"container-title":["Current Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1874467215666220217103233","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/201221\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1874467215666220217103233","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T22:58:00Z","timestamp":1746572280000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/201221\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1874467215666220217103233","relation":{},"ISSN":["1874-4672"],"issn-type":[{"value":"1874-4672","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-09-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}